Fate Therapeutics, Inc. (FATE)
NASDAQ: FATE · Real-Time Price · USD
1.790
-0.135 (-7.01%)
At close: Oct 16, 2026, 4:00 PM EDT
1.730
-0.060 (-3.35%)
Pre-market: Oct 19, 2026, 5:47 AM EDT
Fate Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Oct 5, 2026 |
Unknown Analyst Mizuho Securities No rating | Mizuho Securities | Buy Maintains $8 | Buy | Maintains | $8 | +346.93% | Aug 17, 2026 |
Unknown Analyst Wedbush No rating | Wedbush | Buy Maintains $7 | Buy | Maintains | $7 | +291.06% | Aug 14, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $6 → $8 | Buy | Reiterates | $6 → $8 | +346.93% | Aug 14, 2026 |
Unknown Analyst Wells Fargo No rating | Wells Fargo | Hold Reiterates $2.5 → $3.5 | Hold | Reiterates | $2.5 → $3.5 | +95.53% | Aug 14, 2026 |
| TD Cowen | TD Cowen | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Aug 13, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $7 | Buy | Reiterates | $7 | +291.06% | Jul 9, 2026 |
| Bank of America Securities | Bank of America Securities | Hold Reiterates $2 → $2.2 | Hold | Reiterates | $2 → $2.2 | +22.91% | May 22, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.